Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-233-5 | CAS number: 68526-84-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented study report equivalent or similar to OECD guideline 403: pre-GLP.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 968
- Report date:
- 1968
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 973
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- fixed concentration procedure
- Limit test:
- yes
Test material
- Details on test material:
- - Substance type: Commercial product
-Molecular weight: 144.25
Constituent 1
Test animals
- Species:
- other: mice, rats, guinea pigs
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- No data provided.
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Plexiglas chamber
- Exposure chamber volume: 1000 L
- Source and rate of air: Infusion pump
- System of generating particulates/aerosols: Positive pressure spray nozzle
- Airflow: 63 lpm - Analytical verification of test atmosphere concentrations:
- no
- Remarks:
- Nominal concentraion calculated
- Duration of exposure:
- ca. 6 h
- Concentrations:
- Nominal concentration of 21.7 mg/l
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: Daily for 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology - Statistics:
- No data analyzed.
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 21.7 mg/L air (nominal)
- Exp. duration:
- 6 h
- Mortality:
- 2 rats and 1 mouse succumbed within 14 hours of the termination of the study
- Clinical signs:
- other: All animals became restlessness upon administration of the test material. Dyspnea was noted in several mice. Shallow respiration, closed eyes, and lowered heads were noted in the rats after 20 minutes of exposure and persisted for the duration of the ex
- Body weight:
- Not measured
- Gross pathology:
- The lungs in one rat were adhered to the rib cage and the diaphragm was darker red in color than normal and contained extremely dark red-purple firm areas. One lobe had a firm consistency and was light purple in color. The lungs of the second rat were red with several dark purple areas. Both rats had dark purple livers and dark kidney medullae. The only abnormalities seen in the mouse was a dark medulla and dark kidney pelvis.
- Other findings:
- Gross necropsies performed at the termination of the observation period revealed no abnormalities in 4 mice and 2 guinea pigs. Abnormalities seen in the lungs were tan-gray spots, tan-gray area, white spots, areas of consolidation, gray-purple areas, dark red areas, and an irregular surface. Abnormalities were also noted in the livers of the animals and consisted of areas of discoloration.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute inhalation LC50 for isononanol is >21.7 mg/l.
- Executive summary:
Isononanol was administered via a vapor inhalation to 10 each of mice, rats, and guinea pigs at the nominal concentration of 21.7 mg/l for 6 hours. During the exposure, signs of irritation observed included transient restlessness followed by extreme inactivity, eye irritation, and shallow respiration. Swelling of the rims of the eyes, hyperemia of the ears, and a red-brown encrustation around the nose were noted when the animals were returned to group housing. In addition, three rats and two mice were in a state of collapse. Two rats and one mouse succumbed within 14 hours of the termination of the study. Gross necropsy findings included discolored lungs and livers in the animals. At the end of the study, the LC50 was >21.7 mg/l for each species.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.